Skip to main content
logo
ResMed Inc. (ASX:RMD)
Australia flag Australia · Delayed Price · Currency is AUD
38.59
+0.24 (0.63%)
Nov 12, 2025, 4:10 PM AEST

ResMed Revenue

ResMed had revenue of $1.34B USD in the quarter ending September 30, 2025, with 9.07% growth. This brings the company's revenue in the last twelve months to $5.26B, up 9.36% year-over-year. In the fiscal year ending June 30, 2025, ResMed had annual revenue of $5.15B with 9.84% growth.

Revenue (ttm)
$5.26B
Revenue Growth
+9.36%
P/S Ratio
7.10
Revenue / Employee
$495.98K
Employees
10,600
Market Cap
56.43B AUD

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 20255.15B461.03M9.84%
Jun 30, 20244.69B462.30M10.95%
Jun 30, 20234.22B644.87M18.02%
Jun 30, 20223.58B381.30M11.93%
Jun 30, 20213.20B239.81M8.11%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
CSL Limited23.73B
Ramsay Health Care17.79B
Sonic Healthcare9.65B
Ansell3.06B
Cochlear2.34B
Regis Healthcare1.16B
Telix Pharmaceuticals1.01B
Neuren Pharmaceuticals218.86M
Revenue Rankings

ResMed News

More News